KRAS-induced actin-interacting protein: A potent target for obesity, diabetes and cancer

Anticancer Research

Volumn 31, Issue 7, 2011, Pages 2413-2418

  Fujimoto, Takahiro ^a   Shirasawa, Senji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cancer; Diabetes; KRAP; KRAS; Obesity; Review; Target

Indexed keywords

ACTIN;

BREAST CANCER; CANCER CELL; COLORECTAL CANCER; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIUM CELL; GENE; GENE DELETION; GLUCOSE TOLERANCE; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; KRAP GENE; LIVER CELL; LUNG SMALL CELL CANCER; NEOPLASM; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; UPREGULATION; WEIGHT GAIN; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DIABETES MELLITUS; ENERGY METABOLISM; HUMANS; MEMBRANE PROTEINS; MICE; MICROFILAMENT PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; OBESITY; ORGAN SPECIFICITY; PHENOTYPE; PHYLOGENY; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; THINNESS;

EID: 79961196563     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Boguski MS and McCormick F: Proteins regulating Ras and its relatives. Nature 366: 643-654, 1993. (Pubitemid 24036012)
2. Vigil D, Cherfils J, Rossman KL and Der CJ: Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 10: 842-857, 2010.
3. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B: Prevalence of RAS gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
4. Cho JY, Kim JH, Lee YH, Chung KY, Kim SK, Gong SJ, You NC, Chung HC, Roh JK and Kim BS: Correlation between K-RAS gene mutation and prognosis of patients with non small cell lung carcinoma. Cancer 79: 462-467, 1997. (Pubitemid 27051769)
5. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ and Zalcberg JR: K-RAS mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359: 1757-1765, 2008.
6. Shirasawa S, Furuse M, Yokoyama N and Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88, 1993. (Pubitemid 23122749)
7. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F: Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19 ARF. Cell 103: 321-330, 2000.
8. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, Fukuyama K, Yamamoto K, Mekada E and Sasazuki T: Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling. Cancer Res 60: 6886-6889, 2000. (Pubitemid 32059159)
9. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N and Rak JW: Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression. Blood 105: 1734-1741, 2005. (Pubitemid 40223697)
10. Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki T, Shirasawa S and Grady WM: TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology 136: 1680-1688, 2009.
11. Shirasawa S, Sugiyama S, Baba I, Inokuchi J, Sekine S, Ogino K, Kawamura Y, Dohi T, Fujimoto M and Sasazuki T: Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc Natl Acad Sci USA 101: 13921-13926, 2004. (Pubitemid 39298508)
12. Sugiyama S, Nakabayashi K, Baba I, Sasazuki T and Shirasawa S: Role of epiregulin in peptidoglycan-induced proinflammatory cytokine production by antigen-presenting cells. Biochem Biophys Res Commun 337: 271-274, 2005. (Pubitemid 41393789)
13. Fujimoto T, Miyasaka K, Koyanagi M, Tsunoda T, Baba I, Doi K, Ohta M, Kato N, Sasazuki T and Shirasawa S: Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. PLoS One 4: e4240, 2009.
14. Inokuchi J, Komiya M, Baba I, Naito S, Sasazuki T and Shirasawa S: Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet 49: 46-52, 2004. (Pubitemid 38186125)
15. Fujimoto T, Koyanagi M, Baba I, Nakabayashi K, Kato N, Sasazuki T and Shirasawa S: Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line. J Hum Genet 52: 978-984, 2007. (Pubitemid 350164615)
16. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
17. Kahn BB and Flier JS: Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000. (Pubitemid 30666380)
18. Eckel RH, Grundy SM and Zimmet PZ: The metabolic syndrome. Lancet 365: 1415-1428, 2005. (Pubitemid 40523737)
19. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P and Teule GJ: Cold-activated brown adipose tissue in healthy men. N Engl J Med 360: 1500-1508, 2009.
20. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM and Kahn CR: Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360: 1509-1517, 2009.
21. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerbäck S and Nuutila P: Functional brown adipose tissue in healthy adults. N Engl J Med 360: 1518-1525, 2009.
22. Tseng YH, Cypess AM and Kahn CR: Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 9: 465-482, 2010.
23. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G and Wakil SJ: The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci USA 97: 1444-1449, 2000.
24. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA and Wakil SJ: Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291: 2613-2616, 2001. (Pubitemid 32249687)
25. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM and Friedman JM: Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297: 240-243, 2002. (Pubitemid 34761283)
26. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM and Attie AD: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99: 11482-11486, 2002. (Pubitemid 34920951)
27. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, Carlson S, Helgason A, Walters GB, Gunnarsdottir S, Mouy M, Steinthorsdottir V, Eiriksdottir GH, Bjornsdottir G, Reynisdottir I, Gudbjartsson D, Helgadottir A, Jonasdottir A, Jonasdottir A, Styrkarsdottir U, Gretarsdottir S, Magnusson KP, Stefansson H, Fossdal R, Kristjansson K, Gislason HG, Stefansson T, Leifsson BG, Thorsteinsdottir U, Lamb JR, Gulcher JR, Reitman ML, Kong A, Schadt EE and Stefansson K: Genetics of gene expression and its effect on disease. Nature 452: 423-428, 2008.
28. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, Leonardson A, Castellini LW, Wang S, Champy MF, Zhang B, Emilsson V, Doss S, Ghazalpour A, Horvath S, Drake TA, Lusis AJ and Schadt EE: Variations in DNA elucidate molecular networks that cause disease. Nature 452: 429-435, 2008. (Pubitemid 351450844)
29. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S and Nakamura Y: Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 1: 485-499, 2003. (Pubitemid 36577045)
30. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M and Sommergruber W: Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64: 844-856, 2004. (Pubitemid 38176883)
31. Lin Z, Crockett DK, Jenson SD, Lim MS and Elenitoba-Johnson KS: Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells. Mol Cell Proteomics 3: 820-833, 2004. (Pubitemid 39199582)
32. Murillo H, Schmidt LJ, Karter M, Hafner KA, Kondo Y, Ballman KV, Vasmatzis G, Jenkins RB and Tindall DJ: Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence. Genes Chromosomes Cancer 45: 702-716, 2006.
33. Marincevic M, Mansouri M, Kanduri M, Isaksson A, Göransson H, Smedby KE, Juriander J, Juliusson G, Davi F, Stamatopoulos K and Rosenquist R: Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Haematologica 95: 2072-2079, 2010.